Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial
Multiples Valuation: Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. (REGN)

Industry: Biotechnology Model: Peers Multiples Valuation

Valuation Snapshot

Winsorized Fair Value
Range (Low - High) $414.27 — $1,123.81
Selected (Average) $690.03
Upside to Live -5.87%
Full Range Fair Value
Range (Low - High) $478.07 — $1,375.31
Selected (Average) $885.49
Upside to Live 20.80%
Live Price $733.04

Industry Peers Data

TickerRankNameRev TTM (M) Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
HTBX 1 Heat Biologics, In 6,455,285 - - 8.23 8.23 2.06 -
CELG 2 Celgene Corporatio 16,982 11.93 9.19 9.93 7.76 8.87 7.80
REGN 3 Regeneron Pharmace 14,248 12.73 11.81 10.23 9.41 14.23 15.30
VRTX 4 Vertex Pharmaceuti 11,723 27.24 25.59 20.81 19.14 20.44 22.40
950210.KS 5 Prestige BioPharma 11,056 49.02 49.02 - - - -
688235.SS 6 BeOne Medicines Lt 6,328 43.16 43.16 5.92 5.92 2.69 10.88
ALXN 7 Alexion Pharmaceut 6,262 49.36 36.23 35.23 34.68 12.87 9.06
6160.HK 8 BeOne Medicines AG 6,252 541.45 541.45 100.70 100.70 52.26 186.67
2269.HK 9 WuXi Biologics (Ca 5,276 14.53 5.73 7.99 3.38 8.80 4.05
JAZZ 10 Jazz Pharmaceutica 4,882 - - 30.12 39.52 33.72 -
INCY 11 Incyte Corporation 4,813 13.96 13.96 8.43 8.43 8.22 11.28
ARGX.BR 12 argenx SE 4,611 32.20 32.20 72.71 72.71 46.31 117.00
1177.HK 13 Sino Biopharmaceut 3,929 22.34 21.63 14.29 14.25 11.61 14.04
603233.SS 14 DaShenLin Pharmace 3,809 16.41 16.04 8.77 7.77 13.41 13.01
207940.KS 15 Samsung Biologics 3,729 44.47 32.93 23.31 15.80 24.44 24.25
22UA.F 16 BioNTech SE 3,702 - - - - - -

Implied Valuation Analysis

Line Item Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
Winsorized Median Multiple24.7923.619.938.4311.6111.28
Full Range Median Multiple29.7228.9014.2914.2512.8713.01
Industry Multiple72.1768.9326.6526.0218.9038.22
Market Implied Multiple16.5915.4013.3312.2618.5419.92
Company (REGN) Multiple12.7311.8110.239.4114.2315.30
(*) Net Income / EBITDA / Revenue4,5784,9325,7126,2134,1073,822
Winsorized Enterprise ValueN/AN/A56,71252,36247,66643,126
Full Range Median Enterprise ValueN/AN/A81,61188,53252,87049,737
(-) Net Debt199199199199199199
Winsorized Equity Value113,485116,44856,51352,16347,46742,927
Full Range Median Equity Value136,062142,50981,41288,33252,67149,538
(/) Shares Outstanding104104104104104104
Winsorized Fair Value$1,095.20$1,123.81$545.39$503.41$458.09$414.27
Full Range Median Fair Value$1,313.09$1,375.31$785.68$852.47$508.31$478.07
Current Price$733.04$733.04$733.04$733.04$733.04$733.04
Upside / Downside49.41%53.31%-25.60%-31.33%-37.51%-43.49%
Safety Margin30.0%30.0%30.0%30.0%30.0%30.0%
Buy Price$766.64$786.67$381.77$352.38$320.66$289.99
Buy / Don't BuyBUYBUYDon’t BuyDon’t BuyDon’t BuyDon’t Buy